Epidemiology of Venous Thromboembolism

Overview

Journal Nat Rev Cardiol

Specialty Cardiology & Vascular Diseases

Date 2015 Jun 17

PMID 26076949

Citations 380

Authors

John A Heit

Affiliations

Soon will be listed here.

Abstract

Thrombosis can affect any venous circulation. Venous thromboembolism (VTE) includes deep-vein thrombosis of the leg or pelvis, and its complication, pulmonary embolism. VTE is a fairly common disease, particularly in older age, and is associated with reduced survival, substantial health-care costs, and a high rate of recurrence. VTE is a complex (multifactorial) disease, involving interactions between acquired or inherited predispositions to thrombosis and various risk factors. Major risk factors for incident VTE include hospitalization for surgery or acute illness, active cancer, neurological disease with leg paresis, nursing-home confinement, trauma or fracture, superficial vein thrombosis, and-in women-pregnancy and puerperium, oral contraception, and hormone therapy. Although independent risk factors for incident VTE and predictors of VTE recurrence have been identified, and effective primary and secondary prophylaxis is available, the occurrence of VTE seems to be fairly constant, or even increasing.

Citing Articles

Radiomics of lung ventilation/perfusion tomographic imaging in pulmonary embolism diagnosis.

Liu Y, Wang L, Song H, Wang L, Yang Y, Yang Q Ann Nucl Med. 2025; .

PMID: 40045110 DOI: 10.1007/s12149-025-02037-4.

Development and validation of a deep learning-enhanced prediction model for the likelihood of pulmonary embolism.

Tian Y, Liu J, Wu S, Zheng Y, Han R, Bao Q Front Med (Lausanne). 2025; 12:1506363.

PMID: 39981086 PMC: 11839595. DOI: 10.3389/fmed.2025.1506363.

COVID-19 vaccination and birth outcomes of 186,990 women vaccinated before pregnancy: an England-wide cohort study.

Suseeladevi A, Denholm R, Retford M, Raffetti E, Burden C, Birchenall K Lancet Reg Health Eur. 2025; 45:101025.

PMID: 39974773 PMC: 11838104. DOI: 10.1016/j.lanepe.2024.101025.

A risk prediction model for venous thromboembolism in hospitalized patients with thoracic trauma: a machine learning, national multicenter retrospective study.

Liu K, Qian D, Zhang D, Jin Z, Yang Y, Zhao Y World J Emerg Surg. 2025; 20(1):14.

PMID: 39948568 PMC: 11823207. DOI: 10.1186/s13017-025-00583-w.

Causal relationship between educational attainment and the occurrence of venous thromboembolism.

Guo S, Tan S, Qin S, Xu D, Su H, Chen X BMC Med Genomics. 2025; 18(1):28.

PMID: 39920705 PMC: 11803988. DOI: 10.1186/s12920-025-02092-w.

References

Samama M . An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000; 160(22):3415-20. DOI: 10.1001/archinte.160.22.3415. View

Douketis J, Foster G, Crowther M, Prins M, Ginsberg J . Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med. 2000; 160(22):3431-6. DOI: 10.1001/archinte.160.22.3431. View

de Lange M, Snieder H, Ariens R, Spector T, Grant P . The genetics of haemostasis: a twin study. Lancet. 2001; 357(9250):101-5. DOI: 10.1016/S0140-6736(00)03541-8. View

Danilenko-Dixon D, Heit J, Silverstein M, Yawn B, Petterson T, Lohse C . Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol. 2001; 184(2):104-10. DOI: 10.1067/mob.2001.107919. View

Douketis J, Crowther M, Foster G, Ginsberg J . Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?. Am J Med. 2001; 110(7):515-9. DOI: 10.1016/s0002-9343(01)00661-1. View

Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I . Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation. 2001; 103(20):2453-60. DOI: 10.1161/01.cir.103.20.2453. View

Ray J, Mamdani M, Tsuyuki R, Anderson D, Yeo E, Laupacis A . Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med. 2001; 161(11):1405-10. DOI: 10.1001/archinte.161.11.1405. View

Agnelli G, Prandoni P, Santamaria M, Bagatella P, Iorio A, Bazzan M . Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001; 345(3):165-9. DOI: 10.1056/NEJM200107193450302. View

Merrer J, De Jonghe B, Golliot F, Lefrant J, Raffy B, Barre E . Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001; 286(6):700-7. DOI: 10.1001/jama.286.6.700. View

10.

Zangari M, Anaissie E, Barlogie B, Badros A, Desikan R, Gopal A . Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood. 2001; 98(5):1614-5. DOI: 10.1182/blood.v98.5.1614. View

11.

Heit J, Melton 3rd L, Lohse C, Petterson T, Silverstein M, Mohr D . Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc. 2001; 76(11):1102-10. DOI: 10.4065/76.11.1102. View

12.

Ariens R, de Lange M, Snieder H, Boothby M, Spector T, Grant P . Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state. Lancet. 2002; 359(9307):667-71. DOI: 10.1016/S0140-6736(02)07813-3. View

13.

Rosendaal F, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst F . Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol. 2002; 116(4):851-4. DOI: 10.1046/j.0007-1048.2002.03356.x. View

14.

Folsom A, Cushman M, Tsai M, Aleksic N, Heckbert S, Boland L . A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood. 2002; 99(8):2720-5. DOI: 10.1182/blood.v99.8.2720. View

15.

Tsai A, Cushman M, Rosamond W, Heckbert S, Polak J, Folsom A . Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002; 162(10):1182-9. DOI: 10.1001/archinte.162.10.1182. View

16.

Arnulf I, Perrier A, Birolleau S, Similowski T, Derenne J . Obstructive sleep apnea and venous thromboembolism. JAMA. 2002; 287(20):2655-6. DOI: 10.1001/jama.287.20.2655. View

17.

Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci P . Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost. 2002; 87(5):791-5. View

18.

Oger E . Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000; 83(5):657-60. View

19.

Klatsky A, Armstrong M, Poggi J . Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000; 85(11):1334-7. DOI: 10.1016/s0002-9149(00)00766-9. View

20.

Yin Z, Huang Z, Cui J, Fiehler R, Lasky N, Ginsburg D . Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A. 2000; 97(12):6734-8. PMC: 18721. DOI: 10.1073/pnas.120081897. View